526445 — Indrayani Biotech Balance Sheet
0.000.00%
- IN₹556.45m
- IN₹2.20bn
- IN₹1.30bn
Annual balance sheet for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.79 | 15 | 127 | 5.82 | 2.88 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 78.5 | 154 | 323 | 724 | 1,101 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 96.2 | 189 | 775 | 1,450 | 1,779 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 253 | 259 | 479 | 594 | 600 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 401 | 514 | 1,560 | 2,340 | 2,679 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 118 | 195 | 719 | 871 | 1,025 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 203 | 272 | 1,009 | 1,668 | 1,954 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 197 | 242 | 551 | 672 | 725 |
Total Liabilities & Shareholders' Equity | 401 | 514 | 1,560 | 2,340 | 2,679 |
Total Common Shares Outstanding |